Turkish Journal of Medical Sciences
Volume 47

Number 3

Article 5

1-1-2017

The influence of intraabdominal pressure on the mortalityrate of
patients with acute pancreatitis
PETAR SVORCAN
MAJA STOJANOVIC
PREDRAG STEVANOVIC
ALEKSANDAR KARAMARKOVIC
RADMILO JANKOVIC

See next page for additional authors

Follow this and additional works at: https://journals.tubitak.gov.tr/medical
Part of the Medical Sciences Commons

Recommended Citation
SVORCAN, PETAR; STOJANOVIC, MAJA; STEVANOVIC, PREDRAG; KARAMARKOVIC, ALEKSANDAR;
JANKOVIC, RADMILO; and LADJEVIC, NEBOJSA (2017) "The influence of intraabdominal pressure on the
mortalityrate of patients with acute pancreatitis," Turkish Journal of Medical Sciences: Vol. 47: No. 3,
Article 5. https://doi.org/10.3906/sag-1509-7
Available at: https://journals.tubitak.gov.tr/medical/vol47/iss3/5

This Article is brought to you for free and open access by TÜBİTAK Academic Journals. It has been accepted for
inclusion in Turkish Journal of Medical Sciences by an authorized editor of TÜBİTAK Academic Journals. For more
information, please contact academic.publications@tubitak.gov.tr.

The influence of intraabdominal pressure on the mortalityrate of patients with
acute pancreatitis
Authors
PETAR SVORCAN, MAJA STOJANOVIC, PREDRAG STEVANOVIC, ALEKSANDAR KARAMARKOVIC,
RADMILO JANKOVIC, and NEBOJSA LADJEVIC

This article is available in Turkish Journal of Medical Sciences: https://journals.tubitak.gov.tr/medical/vol47/iss3/5

Turkish Journal of Medical Sciences

Turk J Med Sci
(2017) 47: 748-753
© TÜBİTAK
doi:10.3906/sag-1509-7

http://journals.tubitak.gov.tr/medical/

Research Article

The influence of intraabdominal pressure on the mortality
rate of patients with acute pancreatitis
1,2,

3

2,4

Petar SVORCAN *, Maja STOJANOVIC , Predrag STEVANOVIC ,
2,5
6
2,7
Aleksadar KARAMARKOVIC , Radmilo JANKOVIC , Nebojsa LADJEVIC
1
Department of Gastroenterology and Hepatology, Clinical Center of “Zvezdara”, Belgrade, Serbia
2
Faculty of Medicine, University of Belgrade, Belgrade, Serbia
3
Department of Anesthesiology and Intensive Care, Clinical Center of “Zvezdara”, Belgrade, Serbia
4
Department of Anesthesiology and Intensive Care, Clinical Center of “Dr Dragisa Misovic”, Belgrade, Serbia
5
Emergency Center, Clinical Center of Serbia, Belgrade, Serbia
6
Department of Anesthesiology and Intensive Care, Faculty of Medicine, University of Nis, Nis, Serbia
7
Department of Anesthesiology and Intensive Care, Clinical Center of Serbia, Belgrade, Serbia
Received: 02.09.2015

Accepted/Published Online: 11.01.2017

Final Version: 12.06.2017

Background/aim: Intraabdominal hypertension (IAH) is a common clinical finding in patients with acute pancreatitis and is associated
with poor prognosis. This study aimed to determine the impact of intraabdominal pressure (IAP) on the mortality rate in patients with
acute pancreatitis in an intensive care unit.
Materials and methods: A total of 50 patients with acute pancreatitis were included in this prospective cohort study. Based on the
obtained values of IAP, the patients were divided into two groups: those with normal IAP (n = 14) and increased IAP (n = 36). Mean
values of IAP were compared with examined variables.
Results: The mortality rate of the study group was 40%. Comparing the IAP and treatment outcomes, it was proved that there were
statistically highly significant differences (P = 0.012). Increasing the value of IAP increased the mortality rate. Deceased patients in the
IAH group had greater statistical significance of APACHE II score (P = 0.016), abdominal perfusion pressure (P = 0.048), lactate (P =
0.049), hematocrit (P = 0.039), Ranson’s criteria on admission (P = 0.017), Ranson’s criteria after 48 h (P = 0.010), Sequential Organ
Failure Assessment score (P = 0.014), and body mass index (P = 0.012) compared to the surviving patients.
Conclusion: IAP has an impact on the increase of mortality rates in patients with acute pancreatitis.
Key words: Intraabdominal pressure, intraabdominal hypertension, abdominal compartment syndrome, acute pancreatitis, organ
dysfunction

1. Introduction
The mortality of patients with acute pancreatitis is very high.
Most commonly it occurs as a result of multiple organ damage,
the development of necrotizing pancreatitis, and the presence
of bacterial infection. It was also observed that patients who
die of acute pancreatitis have developed intraabdominal
hypertension (IAH). The massive fluid resuscitation
in the early stages of acute pancreatitis combined with
inflammatory processes in the retroperitoneum results in
visceral edema, which leads to an increase in intraabdominal
pressure (IAP) (1–4). It was observed that patients who die of
acute pancreatitis due to a sudden increase in IAP can have
developed IAH, which leads to early organ damage (5–7).
Until the World Society of Abdominal Compartment
Syndrome (WSACS) conference (8–10), IAH and
* Correspondence: svorcanp@mts.rs
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abdominal compartment syndrome (ACS) incidences
were different in the reports of various hospitals. After the
WSACS conference it was concluded that the incidence
of IAH in acute pancreatitis was 60%. On admission, 70%
of patients already have IAH, and if there is no IAH on
admission it develops during the first days or the IAP
will increase in value. In patients who die the IAP values
are increased, while in others they are gradually reduced
(6,11–13). IAH is defined according to the WSACS
recommendations (10) as the persistent or repeated
pathological increase in IAP to ≥12 mmHg (10). The
diagnostic criteria for acute pancreatitis are defined
according to the American College of Gastroenterology
guidelines (14) as the presence of two out of three of the
following: typical abdominal pain, a threefold increase of
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serum amylase or lipase, and verification of findings for
unclear cases of acute pancreatitis on CT examination (14).
The aim of this study is to determine the impact of IAP on
the mortality rate of patients with acute pancreatitis in an
intensive care unit (ICU).
2. Materials and methods
This prospective cohort study was conducted from
January 2011 to December 2013 in the ICU of Clinical
Hospital Center “Zvezdara”, Belgrade. A total of 50
patients with acute pancreatitis were included in the study.
The diagnostic criteria for acute pancreatitis were defined
according to the American College of Gastroenterology
guidelines (14).
The study was approved by the local medical ethics
committee (Clinical Ctr Zvezdara IRB 1-Medical, No
IRB00003818, Approved by Federalwide Assurance –
FWA00006109). All study participants or their legal
guardians provided informed written consent prior to
study enrollment and there was no conflict of interest.
Based on the WSACS recommendations (10),
observed patients were divided into two groups according
to the mean values of IAP: a group with normal values
of IAP (<12 mmHg) and a group with high levels of IAP.
Furthermore, patients were divided according to the
outcome of treatment in each group separately and were
followed until exiting the ICU.
IAP measurement was performed according to the
recommendations of the WSACS (8). All patients had a
urinary catheter placed into the bladder and the other end
was connected with a three-way stopcock to the urine bag,
and part of the hose from the infusion set was connected
to a measuring ruler marked in centimeters. While
measurements were conducted, the urine bag was taken
off and the hose of an infusion set was attached, through
which 25 mL of sterile saline was injected into the empty
urinary bladder, and was then pinched. The measurement
was performed with the patient in a horizontal position,
comfortably on the back, at the end of the expiratory flow
30–60 s after the injection solution. The zero point was
at the level of the middle axillary line at the iliac crest.
The values obtained were expressed in mmHg, using a
correction factor (1 mmHg = 1.36 cmH2O). Measurements
were performed every 12 h until discharge from the ICU.
Mean values of IAP were compared with studied
variables (age, sex, body mass index (BMI), Acute
Physiology, Age and Chronic Health Evaluation
(APACHE) II score on admission, Sequential Organ
Failure Assessment (SOFA) score, Ranson’s criteria on
admission and after 48 h, abdominal perfusion pressure
(APP), urea, lactate, number of days of treatment).

2.1. Statistical analysis
Analysis of the survey data was performed using SPSS
19.0 for Windows (IBM Corp., Armonk, NY, USA). The
description of numerical characteristics was performed by
methods of descriptive statistics: arithmetic mean and a
measure of variability (standard deviation), as well as the
minimum and maximum values of the characteristics.
In analyzing the results, we used the Student t-test for
comparison between means of two unequal samples.
To analyze the relationship between variables, we used
the Pearson correlation coefficient for homogeneous
data. Simple linear regression was performed for each
independent variable that influenced the dependent
variable for IAP groups with high and normal values of
IAP for deceased patients. For the prediction of mortality
we used a receiver operating characteristics (ROC) curve,
which shows the area under the curve (AUC) for the mean
values of IAP, APACHE II score, APP, and Ranson’s criteria
on admission and after 48 h. In all applied statistical
methods, the level of significance was P < 0.05, and the
level of high statistical significance was P < 0.01.
3. Results
This study included 50 patients with acute pancreatitis,
including 14 with normal values of IAP and 36 with high
levels of IAP. Mortality in patients with acute pancreatitis
in this study was 40%. In the group of patients with
normal pressure the mortality rate was 35.7% (5 deaths
out of 14 patients), whereas in the group with high levels
of IAP the mortality rate was 41.6% (15 deaths out of 36
patients). Comparing the IAP and treatment outcomes, we
have proved that there are statistically highly significant
differences (P = 0.012).
Examined variables of patients with IAH and patients
with normal IAP values are shown in Tables 1 and 2.
Regression analysis showed a significant association
between the mean values of IAP and the examined
variables in groups of deceased patients with normal values
of IAP and IAH (Tables 3 and 4). In the group of deceased
patients with normal IAP, regression analysis did not
confirm a significant strength of the relation between the
tested variables of urea or Ranson’s criteria on admission
and after 48 h. In the group of deceased patients with IAH
the examined variables of age, sex, hematocrit, and urea
did not show statistical significance.
The ROC curve and AUC is shown in the Figure for
prediction of mortality. The Figure shows the AUC for the
mean values of IAP of 0.220 mmHg (95% CI: 0.411–0.985),
APACHE II score of 0.897 (95% CI: 0.131–0.828), APP of
0.302 mmHg (95% CI: 0.342–0.991), and Ranson’s criteria
for admission of 0.197 (95% CI: 0.410–1.00) and after 48 h
of 0.045 (95% CI: 0.603–1.00).
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Table 1. Examined variables of patients with IAH.
Variables

Deceased patients (n=15)

Surviving patients (n=21)

P-value

IAP (mmHg)

18.33 ± 4.18

14.42 ± 2.69

0.001

APACHE II score

27.5 ± 6.13

18.3 ± 4.19

0.016

APP (mmHg)

75.4 ± 16.1

82.7 ± 15.1

0.048

Lactate (mmol/L)

2.3 ± 2.2

2.1 ± 1.9

0.049

Hematocrit (%)

18.3 ± 4.19

35.3 ± 5.78

0.039

Ranson’s at admission

3.0 ± 1.06

1.94 ± 0.93

0.017

Ranson’s at 48 h

3.8 ± 0.94

2.7 ± 1.12

0.010

SOFA score

18.3 ± 4.19

16.3 ± 2.58

0.014

BMI (kg/m )

18.3 ± 4.19

24.2 ± 2.62

0.012

2

IAP: Intraabdominal pressure; APACHE II: Acute Physiology, Age and Chronic Health Evaluation; APP: abdominal perfusion pressure;
SOFA: Sequential Organ Failure Assessment; BMI: body mass index.
Table 2. Examined variables of patients with normal IAP values.
Variables

Deceased patients (n = 5)

Surviving patients (n = 9)

P-value

IAP (mmHg)

10.0 ± 1.00

7.02 ± 2.12

0.01

APACHE II score

23.0 ± 8.37

10.0 ± 1.0

0.014

Ranson’s at 48 h

4.4 ± 0.55

2.6 ± 1.13

0.033

SOFA score

16.4 ± 1.82

12.3 ± 1.5

0.022

BMI (kg/m )

25.9 ± 3.7

22.2 ± 3.46

0.016

2

IAP: Intraabdominal pressure; APACHE II: Acute Physiology, Age and Chronic Health Evaluation; SOFA: Sequential Organ Failure
Assessment; BMI: body mass index.
Table 3. Correlations between the mean values of IAP and the studied variables in deceased patients with normal IAP values.
Variables

R

t

95% CI

P-value

Age (years)

0.941

–4.8

–27.44; –5.56

0.017

Sex

0.45

–0.889

–1.14; –0.645

0.44

BMI (kg/m2)

0.582

–1.24

–7.75; –3.405

0.303

Lactate (mmol/L)

0.696

1.67

–0.23; –0.753

0.023

Hematocrit (%)

0.616

1.35

–5.53; –13.75

0.509

APACHE II score

0.807

–2.365

–15.83; –2.33

0.421

SOFA score

0.638

0.241

–3.05; –3.55

0.951

BMI: Body mass index; APACHE II: Acute Physiology, Age and Chronic Health Evaluation; SOFA: Sequential Organ Failure Assessment.
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Table 4. Correlations between mean values of IAP and the studied variables in deceased patients with IAH.
Variables

R

t

95% CI

P-value

BMI (kg/m )

0.565

–0.23

–0.414; –0.334

0.414

Lactate (mmol/L)

–0.58

2.57

0.043; –0.483

0.023

APP (mmHg)

–0.524

–2.220

–6.19; –0.84

0.045

APACHE II score

0.625

0.831

–0.52; –1.18

0.421

SOFA score

–0.518

–0.064

–0.38; –0.359

0.950

Ranson’s at admission

0.699

1.569

–0.038; –0.242

0.14

Ranson’s at 48 h

0.744

1.323

–0.049; –0.204

0.209

2

BMI: Body mass index; APP: abdominal perfusion pressure; APACHE II: Acute Physiology, Age and Chronic Health Evaluation; SOFA:
Sequential Organ Failure Assessment.

Figure. Receiver operating curve (ROC) for IAP, APACHE II, APP, and Ranson’s criteria at admission and at
48 h.

4. Discussion
According to the latest guidelines (2,6,7,10,14,16,18,19) for
acute pancreatitis it is noted that in recent years admission
to hospitals for acute pancreatitis has increased from 40

to 70 per 100,000. Mortality due to acute pancreatitis
still remains high. Given that a large number of patients
with acute pancreatitis, as part of the pathophysiological
mechanisms and the development of complications,
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develop IAH, with this study we tried to examine how
IAP contributes to the mortality rate in patients with acute
pancreatitis.
Mortality in patients with acute pancreatitis in this
study was 40%. In the group of patients with normal
IAP the mortality rate was 35.7%, whereas in the group
with IAH the mortality rate was 41.6%. The incidence
of IAH was 72%, which is slightly more than in the last
WSACS report (15). According to Keskinen et al. (16),
the incidence of IAH was 84% and the mortality rate with
increasing IAP ranged from 10% to 50%. In a recent study
conducted by Kim et al. (17), which examined the impact
of IAP on the mortality rate in critically ill patients in the
ICU, it was concluded that the IAP had no effect on the
increase in mortality rates if they cured the underlying
condition for which the patient was admitted to the ICU,
because increased IAP appeared as a consequence of the
primary disease. The incidence of IAH in that study was
38%, which is much lower than in our study, but it also
differs because it involves critically ill patients, especially
patients with acute pancreatitis. Another study, which
dealt with patients with acute pancreatitis, showed that the
value of IAP on admission is an equal indicator of mortality
as the SOFA score but a better indicator compared to the
APACHE II score; mortality in that study was 53% (18).
Deceased patients in the study group with IAH had
significantly higher IAP, APACHE II score, APP, lactate
levels, hematocrit, Ranson’s criteria on admission and after
48 h, SOFA score, and BMI compared to surviving patients
of the same group, while the average age, number of days
of treatment, and value of urea did not show statistical
significance. In contrast to them, patients with normal IAP
had a significant association only with the IAP, Ranson’s
criteria after 48 h, and SOFA score, while the APP, lactate
levels, hematocrit, Ranson’s criteria on admission, average
age, number of days of treatment, and value of urea did
not show statistical significance in this group. In this study
it was observed that there was a statistically significant
difference between the values of IAP of deceased patients
with normal IAP and IAH (10.0 ± 1.00 mmHg vs. 18.33 ±
4.18 mmHg, P = 0.035).
In the study group of patients, there was an increase
in IAP, thereby increasing Ranson’s criteria after 48 h and
SOFA score, but this study shows the mean value of the
IAP and not the maximum value. Patients who died in
this group had a mean value of marginal IAP, which were
separated from the group with IAH. Given that there was
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a significant correlation with other parameters, IAP had
an impact.
Both groups of deceased patients had the same
increased variables, and those variables distinguished
them from patients who survived. These variables could
affect the mortality rate, because it is exactly these scoring
systems used to assess the probability of death. In other
studies, it has been proven that patients with acute
pancreatitis had higher values of IAP, APACHE II score,
SOFA score, lactate, and BMI (10,15,19–21).
Deceased patients with IAH had a significant
correlation of IAP with the values of APACHE II score,
Ranson’s criteria on admission and after 48 h, SOFA score,
APP, lactate levels, and BMI, which was confirmed by
linear regression analysis. Given that the high statistical
significance of IAP with these variables differentiated them
from surviving patients, we can say that IAP contributed
to the increase in mortality rates. Deceased patients with
normal IAP had lower values of APACHE II score on
admission, they were younger and had lower BMI, and
Ranson’s criteria were not relevant, but the SOFA score was
significantly associated with IAP.
At the WSACS conference in 2013 (10), there was
debate about whether APP is a better indicator of visceral
perfusion and restitution compared to the mean arterial
pressure. APP had a significant association with IAP in the
deceased group of patients with IAH. Those patients had
reduced values of APP and increased IAP values while APP
was declining. Deceased patients with normal IAP showed
no correlation with APP, but they also had lower APACHE
II scores and other variables examined, and therefore it
had no impact on the outcome. In one recent study, it was
shown that IAP is a better indicator of the severity of acute
pancreatitis compared to APP (22).
The significance of this study lays in the following: it
was conducted according to the WSACS recommendations
with patients with acute pancreatitis who were immediately
admitted to the ICU, the limit for the possible occurrence
of IAH is the value of IAP ≥12 mmHg, and the volume
of fluid used for performing the method is 25 mL. The
limitation of the study is the small number of subjects.
Taking into account all these factors, patients with
acute pancreatitis who develop IAH have a statistically
high correlation with organ dysfunction because the IAH
itself can worsen and lead to death. IAP has an impact
on the increase in mortality rates in patients with acute
pancreatitis.
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